Literature DB >> 9063087

Synthesis of some Mannich bases of 1-cyclohexylidene-N(1,2-dihydro-2-oxo-3H-indol-3-ylidene) thiosemicarbazones and their antibacterial activity.

R P Gupta1, N L Narayana.   

Abstract

Some Mannich bases of 1-cyclohexylidene-N(1,2-dihydro-2-oxo-3H-indol-3- ylidene) thiosemicarbazones have been prepared by employing formaldehyde and morpholine and piperidine as secondary amines. These Mannich bases have been characterised on the basis of different physico chemical evidences. Like some alkaloids, they also form reineckate complexes which serve for their estimation. Antibacterial activity of the synthesised Mannich bases has been studied by employing nine bacterial strains. Chloro group at position 5 broadened the spectrum of activity. Compounds with piperidine showed better activity than the compounds with morpholine, against almost all the organisms used (except 1 or 2 occasions).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9063087     DOI: 10.1016/s0031-6865(96)00027-1

Source DB:  PubMed          Journal:  Pharm Acta Helv        ISSN: 0031-6865


  3 in total

1.  Ethyl 2-[(carbamothioyl-amino)-imino]-propano-ate.

Authors:  Charlane C Corrêa; José Eugênio J C Graúdo; Luiz Fernando C de Oliveira; Mauro V de Almeida; Renata Diniz
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-07-09

2.  Synthesis, characterization, electrochemical studies, and in vitro antibacterial activity of novel thiosemicarbazone and its Cu(II), Ni(II), and Co(II) complexes.

Authors:  Salman A Khan; Abdullah M Asiri; Khalid Al-Amry; Maqsood Ahmad Malik
Journal:  ScientificWorldJournal       Date:  2014-01-09

3.  Synthesis, characterization, computational studies and biological activity evaluation of Cu, Fe, Co and Zn complexes with 2-butanone thiosemicarbazone and 1,10-phenanthroline ligands as anticancer and antibacterial agents.

Authors:  Tahmeena Khan; Iqbal Azad; Rumana Ahmad; Saman Raza; Shalini Dixit; Seema Joshi; Abdul Rahman Khan
Journal:  EXCLI J       Date:  2018-03-29       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.